Absolutely. CAT's actual offering is in the data space, not the device. What makes the CAT product attractive is the data analysis and interpretation capabilities: utilise millions and millions of in-game and training sessions of data of pro-players to determine "who and when will perform better" and "who is under a high risk of injury in today's game". This is not something you can "copy".
Ann: CAT reports solid H1 performance, reaffirms FY18 guidance, page-55
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.68 |
Change
0.140(3.95%) |
Mkt cap ! $638.2M | |||
| Open | High | Low | Value | Volume |
| $3.60 | $3.68 | $3.52 | $3.775M | 1.048M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4112 | $3.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.68 | 4101 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| CAT (ASX) Chart |
